Loading...
Dernières publications
-
Lidia Almenara-Fuentes, Silvia Rodriguez-Fernandez, Estela Rosell-Mases, Katerina Kachler, Axel You, et al.. A new platform for autoimmune diseases. Inducing tolerance with liposomes encapsulating autoantigens. Nanomedicine: Nanotechnology, Biology and Medicine, 2023, pp.102635. ⟨10.1016/j.nano.2022.102635⟩. ⟨hal-03885962⟩
-
Alexandra Bayer Wildberger, Cinthia Bergman, Natalia Pinzon, Axel You, Frédérique Truffault, et al.. Immunomodulation capacities of conditioned mesenchymal stromal cells: benefits and mechanisms in an experimental cell therapy approach for Myasthenia gravis. 7th International Myology Congress, Sep 2022, Nice, France. ⟨hal-03824304⟩
Chiffres clés
56
Publications avec texte intégral
Open Access
46 %
Mots clés
Acides nucléiques endogènes
Quality of life
Gd T cells
Cardiomyopathy
Complete Freund's adjuvant
Experimental mouse models
Interferon
COVID-19
Etiology
Germinal center
Chemokines
Interferonopathy
Anticorps monoclonal
Human myoblasts
Mass cytometry CyTOF
Disease susceptibility
Genetic associations
Genetics
Autoimmunity Inflammation Neuromuscular junction Germinal centers Th17 Muscle regeneration
Interferon-β
Animal models
Innate immunity
Th17 cells
Lamin A/C nuclei
Autoimmunity
Experimental autoimmune myasthenia gravis EAMG
Experimental models
Antimir-150
Inflammatory cytokines
Early-onset myasthenia gravis
Gender
Clinical cell transplantation
Germinal centers
CCL21
Thymic epithelial cells
Macrophages
Glucocorticoids
Heart failure
Experimental autoimmune myasthenia gravis
Maladie auto-immune
Interferon type-I
Interféron de type I
Interleukin 23
Immunology and Microbiology Section
Autoimmune diseases
COX2
Myasthenia Gravis MG
Immune response
BAFF
Acetylcholine receptors
Acetylcholine receptor
FMR1
M3243AG
Interferon de type I
Cytokines
Immunity
Myasthenia gravis
Chemokine
Thymus
Centres germinatifs ectopiques
Cellules th17
LMNA
Acetylcholine receptor antibodies
Ectopic germinal centers
Transcriptome
Thymoma
Follicular hyperplasia
Chronicity
MYB
Interferon IFN
Immune regulation
Chronic inflammation
Immunotherapy
Auto-immunité
Adaptive immunity
CD31
Fragile X syndromes
Aldehyde dehydrogenase biological marker CD31 antigen CD34 antigen CD45 antigen CD56 antigen adipocyte animal experiment animal model animal tissue antigen expression article cell differentiation cell function cell isolation cell labeling cell population cell selection controlled study endomysium enrichment culture enzyme activity enzyme substrate flow cytometry human human cell human tissue immunofluorescence in vitro study in vivo study mouse muscle biopsy muscle contraction muscle injury nonhuman phenotype skeletal muscle stem cell transplantation Adipogenesis Aldehyde Dehydrogenase Cell Differentiation Cells Cultured Flow Cytometry Humans Immunohistochemistry Muscle Cells Muscle Development Muscle Skeletal Phenotype
Myoblasts
DICER
Interferon type I
Max
MG patients
Myasthénie grave
B cells
Conduction disease
CXCL13-CXCR5
AChR antibodies
Inflammation
Ferrites
Endogenous nucleic acids
Il-23
Long-term follow-up
Interleukine-23
PBMC
Exercise
Age
CTCF
Neuromuscular junction
Autoimmune disease